PYRAZINAMIDE is an antibiotic medication primarily used in the treatment of tuberculosis (TB). It works by inhibiting the growth of the bacteria that cause TB, making it an essential component of multi-drug regimens for effective disease management.
PYRAZINAMIDE is indicated for use in combination with other antitubercular agents for the treatment of active tuberculosis in adults and pediatric patients. It is particularly effective in the initial phase of treatment.
The exact mechanism of action of PYRAZINAMIDE is not fully understood. However, it is thought to disrupt the bacterial cell membrane metabolism and transport functions, leading to the death of the Mycobacterium tuberculosis organism.
PYRAZINAMIDE is typically administered orally, and the dosage may vary based on the patient's age, weight, and the severity of the infection. It is essential to follow a healthcare provider's instructions for appropriate dosing.
Common side effects of PYRAZINAMIDE may include:
Serious side effects may occur, and patients should be monitored for liver function and other potential complications during treatment.
Prior to starting treatment with PYRAZINAMIDE, patients should inform their healthcare provider of any liver disease, gout, or other medical conditions. Regular monitoring of liver enzymes is recommended during therapy.
PYRAZINAMIDE may interact with other medications. It is vital to discuss all current medications, including over-the-counter drugs and supplements, with a healthcare provider to avoid potential interactions.
Store PYRAZINAMIDE at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
PYRAZINAMIDE is a critical medication in the fight against tuberculosis. When used appropriately in combination with other antitubercular agents, it can significantly improve treatment outcomes. Always consult with a healthcare professional for personalized advice and treatment plans.